Krishnan, Navasona
Koveal, Dorothy
Miller, Daniel H
Xue, Bin
Akshinthala, Sai Dipikaa
Kragelj, Jaka
Jensen, Malene Ringkjøbing
Gauss, Carla-Maria
Page, Rebecca
Blackledge, Martin
Muthuswamy, Senthil K
Peti, Wolfgang
Tonks, Nicholas K
Article History
Received: 11 December 2013
Accepted: 16 April 2014
First Online: 20 May 2014
Competing interests
: A company called DepYmed Inc. was founded on 3 March 2014 with the primary purpose of taking MSI-1436 into the clinic in patients with HER2-positive breast cancer. It is owned equally by Ohr Pharmaceuticals and Cold Spring Harbor Laboratory. Authors N.K. and N.K.T. are entitled to a share based on the conditions of the Invention Agreement signed by all of the scientists at Cold Spring Harbor Laboratory.